Comparability assessments of process and product changes made during development of two different monoclonal antibodies-Reference-Cited by-同舟云学术

Comparability assessments of process and product changes made during development of two different monoclonal antibodies

Published:2011-01 Issue:1 Volume:39 Page:9-22
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Lubiniecki Anthony,Volkin David B.,Federici Marcia,Bond Michael D.,Nedved Michael L.,Hendricks Linda,Mehndiratta Promod,Bruner Mark,Burman Sudhir,DalMonte Paul,Kline Jane,Ni Alex,Panek Mark E.,Pikounis Bill,Powers Gordon,Vafa Omid,Siegel Rich

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference19 articles.

1. Comparability is not just analytical equivalence;Lubiniecki;Biologicals,2006

2. Characterizing biological products and assessing comparability following manufacturing changes;Chirino;Nat Biotechnol,2004

3. Comparability testing of a humanized monoclonal antibody (Synagis®) to support cell line stability, process validation, and scale-up for manufacturing;Schenerman;Biologicals,1999

4. The impact of glycosylation on the biological function and structure of immunoglobulins;Arnold;Annu Rev Immunol,2007

5. Characterizing biological products and assessing comparability following manufacturing changes;Chirino;Nat Biotechnol,2004

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-centric Comparability Assessment of Biopharmaceuticals;Journal of Pharmaceutical Sciences;2024-06

2. A Review of Recent FDA-Approved Biologic-Device Combination Products;Journal of Pharmaceutical Sciences;2023-12

3. An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals;Journal of Pharmaceutical Sciences;2023-12

4. Biosimilarity is not a transitive property: implication for interchangeability, naming and pharmacovigilance;Generics and Biosimilars Initiative Journal;2022-04-15

5. Process Development of Protein Therapeutics;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26